Privia Health Group, Inc. (NASDAQ:PRVA) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Privia Health Group, Inc. (NASDAQ:PRVA) has been assigned an average rating of “Moderate Buy” from the fourteen analysts that are presently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have given a buy rating to the company. The average 1-year price target among brokerages that have issued ratings on the stock in the last year is $28.9091.

A number of analysts have weighed in on PRVA shares. Evercore ISI cut their price objective on shares of Privia Health Group from $30.00 to $28.00 and set an “outperform” rating on the stock in a report on Wednesday, July 9th. Stephens reissued an “overweight” rating and set a $32.00 price objective on shares of Privia Health Group in a report on Wednesday, September 24th. Piper Sandler cut their price objective on shares of Privia Health Group from $36.00 to $35.00 and set an “overweight” rating on the stock in a report on Monday, August 11th. Weiss Ratings reissued a “sell (d+)” rating on shares of Privia Health Group in a report on Wednesday, October 8th. Finally, Zacks Research raised shares of Privia Health Group from a “strong sell” rating to a “hold” rating in a report on Tuesday, August 19th.

Hedge Funds Weigh In On Privia Health Group

A number of institutional investors have recently modified their holdings of the business. State Street Corp increased its holdings in shares of Privia Health Group by 1.5% in the 2nd quarter. State Street Corp now owns 4,171,069 shares of the company’s stock valued at $95,935,000 after acquiring an additional 61,853 shares during the period. Geode Capital Management LLC grew its position in Privia Health Group by 6.3% in the 2nd quarter. Geode Capital Management LLC now owns 2,655,569 shares of the company’s stock valued at $61,086,000 after buying an additional 158,521 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in Privia Health Group by 180.4% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 2,633,040 shares of the company’s stock valued at $59,112,000 after buying an additional 1,693,870 shares during the last quarter. Van Berkom & Associates Inc. purchased a new position in Privia Health Group in the 1st quarter valued at $45,207,000. Finally, Northern Trust Corp grew its position in Privia Health Group by 2.2% in the 1st quarter. Northern Trust Corp now owns 1,423,865 shares of the company’s stock valued at $31,966,000 after buying an additional 31,224 shares during the last quarter. 94.48% of the stock is owned by institutional investors and hedge funds.

Privia Health Group Trading Up 1.9%

PRVA stock opened at $24.76 on Tuesday. Privia Health Group has a twelve month low of $18.50 and a twelve month high of $26.49. The company’s 50 day moving average is $23.96 and its two-hundred day moving average is $22.73. The stock has a market cap of $3.04 billion, a P/E ratio of 225.11, a PEG ratio of 3.31 and a beta of 0.83.

Privia Health Group (NASDAQ:PRVA) last released its quarterly earnings data on Tuesday, June 7th. The company reported $0.10 earnings per share for the quarter. Privia Health Group had a net margin of 0.78% and a return on equity of 2.13%. The company had revenue of $213.61 million for the quarter. On average, equities research analysts predict that Privia Health Group will post 0.14 earnings per share for the current year.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.